INSMED (INSM) cash: $510M
INSMED held $510M in cash and cash equivalents on Dec 31, 2025, down 8.0% from $555M a year earlier.
From INSMED's filings with the SEC · Read the filing · INSM stock page
INSMED cash by year
#871 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $510M | -8% |
| Dec 31, 2024 | $555M | +15% |
| Dec 31, 2023 | $482M | -55% |
| Dec 31, 2022 | $1.1B | +50% |
| Dec 31, 2021 | $717M | – |
Cash of similar companies
Companies in the same industry as INSMED, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| Organon | $574M | Dec 31, 2025 |
| BridgeBio Pharma | $570M | Dec 31, 2025 |
| Innoviva | $551M | Dec 31, 2025 |
| Elanco Animal Health | $545M | Dec 31, 2025 |
| PERRIGO | $532M | Dec 31, 2025 |
| INSMED | $510M | Dec 31, 2025 |
| NewAmsterdam Pharma | $490M | Dec 31, 2025 |
Questions and answers
What is INSMED's cash?
INSMED held $510M in cash and cash equivalents on Dec 31, 2025, down 8.0% from $555M a year earlier.
Numbers as reported in INSMED's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology